VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 665 filers reported holding VANECK VECTORS ETF TR in Q3 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $3,235,000 | -61.7% | 100,000 | -71.4% | 0.02% | -56.1% |
Q3 2022 | $8,442,000 | -86.1% | 350,000 | -77.9% | 0.04% | -80.5% |
Q1 2022 | $60,660,000 | +1630.2% | 1,581,748 | +1345.1% | 0.21% | +2900.0% |
Q4 2021 | $3,506,000 | +962.4% | 109,456 | +877.3% | 0.01% | +600.0% |
Q3 2021 | $330,000 | -13.4% | 11,200 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $381,000 | -99.8% | 11,200 | -99.8% | 0.00% | -99.8% |
Q4 2020 | $216,120,000 | +4471.1% | 6,000,000 | +4554.8% | 0.57% | +1451.4% |
Q2 2020 | $4,728,000 | – | 128,900 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Harbor Financial Group, LLC | 2,418,400 | $77,461,000 | 26.62% |
Brevan Howard Capital Management LP | 1,000,000 | $32,030,000 | 23.21% |
Windmill Hill Asset Management Ltd | 844,600 | $27,053,000 | 19.48% |
Memorial Sloan Kettering Cancer Center | 738,500 | $23,654,000 | 14.86% |
New Harbor Financial Group, LLC | 1,286,391 | $41,203,000 | 14.16% |
Eschler Asset Management LLP | 300,000 | $9,609,000 | 12.30% |
Hollow Brook Wealth Management LLC | 712,669 | $22,827,000 | 11.71% |
Grand Central Investment Group | 284,547 | $9,114,000 | 10.90% |
Baymount Management LP | 500,000 | $16,015,000 | 9.54% |
Nokomis Capital, L.L.C. | 512,628 | $16,419,000 | 6.93% |